Try our Advanced Search for more refined results
Life Sciences - May, 2017
341 articles
- PE-Backed IPOs, Biotech Deals Push 2 Firms Ahead Of Pack
- Fed. Circ. Rules PTAB Wrongly Axed Spinal Surgery Patent
- FDA Assails Amgen's Sensipar Exclusivity Suit
- Janssen Can't Escape Bulk Of FCA Suit Over HIV Drug
- Boston Scientific, St. Jude Can't Beat UC Patent Claims
- AbbVie Tops Pharma Reputation Report, Pfizer Ranks Last
- Merck Ducks Fraud Claims In Pa. Zostavax Suits
- EpiPen Maker Says Securities Fraud Allegations Don't Add Up
- Attys Sued For Malpractice Over Tossed Novartis Suit
- Reed Smith Adds Life Sciences Partner In Chicago
- Attys Face $25K In Fees After Enbrel Suit Discovery Row
- Compliance And The Transition To Value-Based Care
- The Return Of Attorney-Conducted Voir Dire
- DaVita Investors Sue Execs Over Alleged Insurance Scheme
- Covidien Gets Dissolving Suture Suit Tossed
- FDA Warning Wire: Device Maker Too Slow To Probe Defects
- Deals Rumor Mill: Miami Marlins, Mallinckrodt, E.ON
- Pfizer Seeks 6-Year Clock, Not 2, In Tossed $8M Tax Suit
- FedEx Dropped From QR Code Patent Suit
- Pharmacist Rips Feds' 'Face-Saving' After Murder Acquittals
- Gray Matters: Identities Are Us
- Justices Won't Review Parents' Vaccine Injury Suit
- The On-Sale Bar And USPTO Practices After Helsinn
- Kimberly-Clark Wants New Trial After $454M Fraud Verdict
- Hedge Fund Fights FINRA Bid To Ditch Bogus Payout Suit
- FTC Would Shred Privilege In Aggrenox Suit, DC Circ. Told
- Family Dredges Up Pradaxa Manufacturer's Discovery Woes
- AbbVie Fights Evidence Ahead Of Testosterone Bellwether
- Intra-Cellular Hid Drug Issues Before FDA Probe, Suit Says
- The Firms That Lost The Most Ground In 2016
- The Firms That Grew Fastest Without Merging
- Turning 50, Greenberg Traurig Tops The Law360 400
- Law360 Reveals 400 Largest US Firms
- The Law360 400
- Biggest US Firms Opt For Modest Growth In Sluggish Market
- Ethicon Seeks High Court Review In $3M Pelvic Mesh Suit
- Dallas Morning News Must Face Libel Suit Over Pharma Series
- Amgen Sues FDA Over Exclusivity For Blockbuster Sensipar
- Omnicare Pays $23M To End Kickback, Medicaid Fraud Suit
- J&J's Aveeno Settles 'Natural' Labeling Suit For $6.75M
- Drug Settlement Malpractice Suits Rightly Tossed: 10th Circ.
- Instant Coffee Sex Aid Recalled After Report Of Death
- Consumer Agrees To Dismiss Suit Over CVS Vitamins
- Bard Ends 97 More Suits In Pelvic Mesh MDL
- J&J Hit With $2.16M Verdict In 4th Philly Mesh Case
- Fed. Circ.'s Approach To Unexpected Results In Pharma Cases
- TC Heartland Adds To Fed. Circ. Losing Streak At High Court
- FDA Chief Vows Action On Generic Approvals, Obstruction
- Pharma Cos. Say No Fraud Claimed In Cancer Drug Size Suit
- Zimmer Knee Implant Cases Will Move Forward As MDL
- Deals Rumor Mill: Staples, Web.com, Stada
- GSK Seeks New Trial In Reed Smith Atty Suicide Case
- Teva To Pay $1.6M To Resolve Calif. Counties' Opioid Suit
- My Milkshake Is Better Than Yours: Part 2
- Drug Wholesalers Blast Forest's Bid For Profit Docs
- Chinese Cos. Buy Condom, Sexual Wellness Biz For $600M
- Pfizer Says Expert Testimony In Celebrex Suit Unreliable
- Biogen Asks Judge To Toss Neurological Drug Antitrust Suit
- Michigan Law Correctly Applied In Stryker Noncompete Suit
- Extending Omnicare Beyond The Section 11 Case
- The Next Steps For Biometrics Legislation Across The US
- UC, Medivation Settle Drug Royalty Row On Eve Of Trial
- Ex-Heritage Execs To Help States Probe Drug Price-Fixing
- Theranos Dodges Investors' 'Boundless' Docs Bid, For Now
- Judge Won't Wade Into Mich. Biopharma Co.'s Proxy Fight
- PTAB Finds University Of Md. Is Immune From IP Review
- Novo Nordisk, Benefit Co. Conspired To Hike Prices, Suit Says
- 3rd Circ. Ends Amarin Shareholder Row Over Heart Drug
- My Milkshake Is Better Than Yours: Part 1
- Jury Readies To Mull 4th Philly Pelvic Mesh Case
- Costco, NBTY Can't Shake Supplement Label Row, Court Told
- Bristol-Myers, Pfizer Made Faulty Blood Thinner, Suit Says
- Mylan, IRS Ink Deal To Avoid Trial On Nebivolol Transaction
- State AGs Announce $33M Deal With J&J Over OTC Drugs
- A Potent Weapon For Fighting False Ad Claims At 9th Circ.
- FDA Delivers 1st Drug Promo Rebuke Under Trump
- Depakote Ingredient Causes Spina Bifida, Expert Tells Jury
- AIA Trial Institution Rates Are Good News For Patent Owners
- Plaintiffs Bar Perspective: Ratzan Law Group's Stuart Ratzan
- Patients Slam Bayer, Janssen's Bid To Cut Xarelto Claims
- Abbott's Depakote 'Most Toxic' Drug For Fetuses, Jury Told
- FDA Warning Wire: Pharma Staff Kept Info 'In Their Heads'
- Korean Ultrasound Co. Must Pay $3M Arbitration Award
- Lilly's $20M Cialis Patent Verdict Stayed During Appeal
- Generic Drug Price-Fixing MDL Fuels Worries For Defendants
- Deals Rumor Mill: Sinochem, Constellation, Delivery Hero
- Back To The Fourco: High Court's New, Old Patent Venue Test
- Latest J&J Pelvic Mesh Injury Case Kicks Off In Philly
- Judge Greenlights Merck's $60M Deal In Pay-For-Delay MDL
- 40 States Defend Power To Bring Generic-Drug Price-Fix Suit
- Benicar MDL Judge Dismisses Doc Accused Of Malpractice
- Zeltiq's Disclosures Mooted Suit, But Not Fees, Investor Says
- UK Watchdog Accuses Merck Of Arthritis Drug Scheme
- Attorneys, Your Input Is Needed On Deposition Rule
- Learning From Social Media For Adverse Event Reporting
- Bayer Seeks To Collect $455M Award In Dow Patent Row
- Damage Calculations Trimmed In Provigil Pay-For-Delay Row
- 5 Key Debates Over FDA's Interchangeable-Biosimilar Views
- 3 Takeaways From The Supreme Court's Patent Venue Ruling
- Attorneys React To Supreme Court Patent Venue Ruling
- Trade Secrets Suit Based On Forged Letter, Pharma Co. Says
- Roxane Owes $2M In Attys' Fees In 'Exceptional' Patent Row
- Concert Pharma Gets 2nd FTC Request Over Vertex Deal
- Investors Target NewLink Execs Over Failed Cancer Vaccine
- Buyers Want GSK, Teva To Cough Up Info In Lamictal Suit
- The EDTX Exodus: How TC Heartland Narrowed IP Venues
- Stolen Trade Secrets Cost Pharmacy $2M Per Month, Suit Says
- Shkreli Wins Grand Jury Subpoenas In Securities Fraud Suit
- Morgan Lewis Adds Corporate, Transactional Attys In Houston
- Pharma Co. Says Rosen Firm's Conflicted In Stock Drop Case
- Kirkland, Paul Weiss Assist On $446M Sale Of Nutraceutical
- 2 Rules For Avoiding Cannabis-Related Property Traps
- The Supreme Court Puts Personal Jurisdiction On Trial
- Opinions Of Counsel Post-Halo: Lessons From 16 Cases
- High Court Limits Where Patent Suits Can Be Filed
- IRS Looks To Enforce Teva Summons In Charity Inquiry
- NJ Drug Co. Dodges Class Action Over FDA Approval Claims
- 3rd Circ. Questions Early End To Lipitor Pay-For-Delay Suit
- Target, Wal-Mart Can't Dodge Herbal Supplement MDL Claims
- Investors Drop Suit Over $204M Derma Sciences Merger
- Supplement Co. Says Rival Sells Carcinogenic Products
- Hospira Comes Out $40K Ahead In Verdict Against GSK
- Fed. Circ. Upholds Injunction In Mylan Dye Patent Case
- Part Of Apriso Patent Nixed In IPR With Hedge Fund Ties
- Taxation With Representation: Skadden, Wachtell, Vinson
- Sanctions ​And Export Control Risks For Health Care Cos.
- Arix Bioscience Leads $65M Funding Round For Iterum
- Steward To Create US Hospital Operating Giant With IASIS Buy
- Health Hires: Burns & Levinson, Nossaman
- Recognizing The Fallacy Of 'Right To Try' Legislation
- Ariz. Appeals Court Tosses 'Dirty' Medical Device Suit
- CIT Grants Duty-Free Status To Some Compression Garments
- Patent Litigator Joins Quinn Emanuel From Kirkland & Ellis
- 7th Circ. Tells Eli Lilly To Restore Ill Worker's Benefits
- 3rd Circ. Could Up Ante For Buyers In Pay-For-Delay Cases
- How Client Feedback Programs Benefit Law Firms And Clients
- $330M Award Against Czech Republic OK'd In Luxembourg
- Drugmaker Says Middleman Overbilled It For Services
- Lilly Ordered To Pay Jury's $20M Cialis Patent Verdict
- Chinese Educator, Dutch Biotech Raise $258M In US IPOs
- Mylan, Pfizer Say EpiPen Antitrust Suits Don't Need MDL
- 'Natural' Sex Drugs Hide Harmful Ingredients, Suit Says
- A Look At 1st-Party Insurance Coverage For Cannabis
- GSK Makes $24M Demand As Hospira Trial Wraps
- Shkreli Loses Bid To Suppress Docs In Securities Fraud Case
- Cook Medical Wins Bid To Trim Vein Filter Claims Before Trial
- Pfizer, La. End Neurontin Antitrust Suit With $1M In Naloxone
- PTAB Invalidates Humira Patent In Coherus Challenge
- Medtronic Ordered To Pay $23.5M In Patent Infringement Case
- Bipartisan Bill Again Calls For Transparency In Settlements
- Fed. Circ. Won't Put $455M Bayer Patent Award On Hold
- Express Scripts Says Kaléo Owes $14.5M In Naloxone Rebates
- Foreign Boehringer Units Look To Ax Aggrenox MDL Claims
- G1 Therapeutics Raises $105M In IPO Guided By Mintz Levin
- Lead Plaintiff Swap Doesn't Cost $37K, Counsel Says
- Zimmer Attacks Breakup Bid In Knee-Replacement MDL
- How Brazil's Corruption Crackdown Affects Health Care
- Uncertainty In Patent Term Extension For Biologics
- Privacy, Security And The Internet Of Medical Things
- AIPLA Proposes Bill To Overhaul Patent-Eligibility Law
- FDA Warning Wire: Drug Ingredients In Soda Bottles
- 6 Sentenced In $172M Health Insurance Fraud Scheme
- Ex-InterMune Director Barred From Boards For Insider Trading
- Legislation Could Ease Litigation On Fla. Medical Pot Laws
- Amputation Risk Leads To Boxed Warning On Diabetes Drugs
- Express Scripts Won't Get Quick Win Redo In Breach Suit
- Valeant, Pershing Square Balk At Draft Class Action Notices
- Kimberly-Clark Dodges Injunction After $454M Fraud Verdict
- Merck Seeks OK For $60M Settlement In Pay-For-Delay Row
- PE-Backed Cable Giant WideOpenWest Launches $400M IPO
- Using High Court's Failure To Define 'Component' In Promega
- Solving The Legal Industry's Data Protection Breakdown
- Ex-InterMune CEO Says Expert Would Have Changed Verdict
- 26 States Rejoin FCA AstraZeneca Suit Over Seroquel
- Ex-Katten Atty Looks To Gut Indictment In Shkreli Case
- 3 Firms Get $27M Payday In Elan Investors' SAC Capital Suit
- Sanofi Fights Bid To Combine EpiPen Suits Against Mylan
- Deals Rumor Mill: Stada, Ticketfly, Indigo
- Generics Copied Reckitt's Cough Drug Patents, Court Told
- Medtronic Settles Heart Valve Patent Suit After Venue Fight
- Energy MLP, Cancer-Focused Biotech File IPOs Totaling $200M
- Thermo Fisher Readies $7.2B Patheon Buy
- 5 Things To Know About Justice Gorsuch's First 30 Days
- 1st Circ. Upholds Biogen's Win In Drug Sales Forecast Suit
- Ex-NFLer Says Biz Fired Him For Reporting Harassment
- Why Florida Pharmaceutical Compounders Should Be Wary
- Justices Reject Sheller Appeal Over Risperdal FDA Petition
- EU Antitrust Watchdog Probes Aspen's Cancer Med Pricing
- Forest Wants At Least $6M In Fees After Atty Misconduct
- Ex-WilmerHale IP Atty Returns To Wolf Greenfield
- 'Pre-Approval' Design Defects? There's No Such Thing
- Judge Says Pfizer's $8.3M Tax Suit Brought Too Late
- 5 Mistakes That End Law Firms
- Fed. Circ. Denies Dow Review Of $455M Bayer Patent Award
- Miss. Wants Medicare Reimbursement Suit In State Court
- Foundation Asks For Treble Damages In Hearing Aid IP Case
- 4 Firms To Lead 3 IPOs Raising $300M, Led By Biotech Cos.
- Ex-MLB Player DeCinces Convicted In Insider Trading Case
- Shkreli Probe Not Finished, Prosecutor Tells NY Trial Judge
- Candela Can't Nix Surgeon's Suit Over Weight Reduction Tool
- Taxation With Representation: Debevoise, Sullivan, Fried
- What Braintree Means For Intent To Induce Infringement
- Kerr Russell Cops To Aiding Eavesdropping On Depositions
- The Case For A Lawyer As Chief Operating Officer
- 9th Circ. Won't Revive Sanofi Patent FCA Suit
- Excess Insurer Says Akorn Not Covered For $20M Verdict
- Intuniv Buyers Fight Actavis Bid To Nix Pay-For-Delay Suit
- Drug Wholesaler Gets 5 Years In Prescription Meds Fraud
- Bio-Rad Can't Get New Trial Over $8M Jury Verdict For Ex-GC
- Amgen Patent Suit Targets Coherus' Neulasta Biosimilar
- Clovis Shareholder Sues Over Directors' Lofty Pay
- Complicated Landscape Awaits New FDA Commissioner
- A Guide To Competitive Marijuana Licensing Applications
- Patenting An Interface Between Human Brain And Computer
- GE, Infant Product Co. Reach Deal In Incubator Patent Case
- Cherokees' Opioid Suit A Test For Tribal Courts' Reach
- Novartis Says Gleevec Antitrust Suit Should Remain Paused
- 5 Top Priorities As Gottlieb Takes Reins At FDA
- Watson Seeks Quick Win In Suit Over FTC Litigation Powers
- Astellas Sues Roxane Over Generic Cancer Drug ANDA
- Solomon Gets Nearly $5M In Spirogen Sale Dispute
- Fraudster Must Pay $130.2M In Restitution, Fla. Judge Says
- Texas Suit Over Death Penalty Drug Faces Steep Odds
- MDL Lead Attys Face Class Action Over Dismissed Yaz Suits
- Pharma Co. Dodges Shareholder Suit Over Failed Antibiotic
- 6 Habits Of A Successful Tech Lawyer
- Fed. Circ. Affirms PTAB's Invalidation Of NuVasive Patents
- Pfizer Settles Fee Dispute In $785M FCA Deal
- Vitamin Shoppe Sued Over Supplement's Weight Loss Claims
- Value-Based Health Care: 10 Things Investors Should Know
- Mylan's 3rd Circ. Doryx Loss A Hurdle To Product-Hop Suits
- INC Research, InVentiv Ink $7.4B Tie-Up
- Test Strip Makers Agree On Sanctions For Eavesdropping
- Robins Kaplan Partner Departs To Open IP Boutique In NYC
- Questioning The Controlled Substances Act After Enmon
- How China Became An IP Superpower
- Rare Grable Removal Sighted In Missouri
- Mylan, IRS Trade Opening Shots Ahead Of $100M Tax Trial
- Ill. Mom Says Ind. Time Limits Don't Apply In Depakote Case
- Ex-Lutonix VP Pleads Guilty To Trade Secret Theft
- FDA Warning Wire: Inspection Foiled By Fishy Worker Strike
- Bristol-Myers, Pfizer Escape Suit Alleging Eliquis Risks
- 4th Circ. Backs Boston Scientific Win In Pelvic Mesh Suit
- Trump Pick For FDA Commissioner Approved By Senate
- Pharmacist Gets Prosecutor's Evidence During Acquittal Bid
- Shire Loses Fed. Circ. Appeal In Generic Infringement Suit
- Feds Hit Back At Shkreli's Password-Cracking Allegations
- Wilson Sonsini Snags Former Del. Supreme Court Justice
- Third Of Approved Drugs Need Safety Follow-Up, Study Finds
- Expect Change At The Consumer Product Safety Commission
- J&J Discloses Fed. Probes Over Arthritis Drugs, Copayments
- Eyelid Scrub Maker Loses Bid To Block Walgreen Products
- Kimberly-Clark Fights Injunction After $454M Fraud Verdict
- Biotech Investor Wants Details Of Stock Swap Plan
- Medtronic Fights Extra Damages In $17M Infringement Case
- Zimmer Implant MDL Plaintiffs Seek Return To Home Courts
- Boston Scientific Looks To Dodge Mo. Pelvic Mesh Cases
- Class Cert. Denied In TCPA Suit Against Medical Supply Co.
- Trustee Drops Unilife Bonus Plan Fight After Testimony
- Takeda, Generics Push To Toss Actos Buyers' Antitrust Suit
- Deals Rumor Mill: Toshiba, Parexel, Kinder Morgan
- GSK Seeks To Strike Fraud Claims In Zofran MDL
- Pa. Court Upholds Pfizer Win In Zoloft Birth Defect Suit
- The ITC's Evolving Approach To Cease And Desist Orders
- AbbVie Can't Dodge Consumers' Claims In Testosterone MDL
- FDA Rejects Vaginal Pain Treatment
- Arizona's Off-Label Promotion Law May Hinge On Gottlieb
- 3 Cos. Launch IPOs Totaling $300M Led By Biotech Firms
- NuVasive Asks Fed. Circ. To Revive Spinal Surgery Patents
- J&J Opens 4th Pelvic Mesh Trial In Philadelphia
- Feds Chide Meningitis Fraudster's 'Unhinged' Acquittal Bid
- Protecting Privilege, Work-Product During Investigations
- 9th Circ. Sets New Falsity Standard, Citing Omnicare
- Jury Clears Zimmer In Hip-Implant Suit
- USTR Pick To Move Forward Next Week, McConnell Says
- 2 Cos. Price IPOs Totaling $285M Led By KKR-Backed REIT
- FDA Leaders Dish On Agency Policies Under Trump
- Pharma Tries To Nix Shareholder Suit Over Failed Antibiotic
- Fed. Circ. Undoes Breckenridge Generic Laxative Patent Win
- 8th Circ. Tosses FCA Suit Over Drug Price Inflation
- Retrophin Slams Shkreli's Move For Katten Muchin Docs
- Amphastar Fights Momenta, Sandoz Bid To Duck Antitrust Suit
- Animal Feed Company Must Stop Making Medicated Feeds
- Simpson, Kirkland Steer $6.4B Laboratory Products Merger
- Sanofi Escapes Health Plans' 'Deficient' Kickback Suit
- Fraudsters Owe $130M In $175M Insurance Scheme, Feds Say
- US Trustee Takes Aim At Unilife's $1M Exec Bonus Plan
- Feds Want Up To 10 Years For Wholesaler In Rx Fraud Scheme
- 3 Takeaways From First Xarelto Trial
- AbbVie Investors Sue In Chancery Over $55B Shire Merger
- J&J Hit With $110M Verdict In Latest Mo. Talc Cancer Trial
- IHS Details Steps To Fight Opioid Crisis Among Tribes
- Unilife Gets Approval For Company Sale In Del. Ch. 11
- Theranos Shrugs Shoulders On Adding Funds To Investor Suit
- Syngenta Fights Consolidation Bid For GMO Corn Cases
- Eli Lilly Cleared To Sue Cialis Counterfeiter
- Forest Blasts Bid For Namenda Patent Litigation Docs
- EU Urged To Probe Gilead, Novartis, Roche, Aspen Pricing
- Congress Should Increase Penalties On Internet Pharmacies
- Lab Services Market Remains Ripe For Private Equity
- 13 FCPA Enforcement Actions Resolved In 2017 So Far
- Jury Asked To Punish 'Reprehensible' J&J In Talc Cancer Row
- Mylan Won't Appeal 3rd Circ. Loss On Doryx Generic
- 10th Circ. Sends Part Of Clomid Defect Suit Back To Utah
- Fed. Circ. Suggests AIA May Not Have Weakened On-Sale Bar
- 11th Circ. Gives Ex-DePuy Exec 2nd Shot At Noncompete
- Generic-Drug Makers Want 40-State Price-Fix Suit Dropped
- J&J Asks 5th Circ. To Toss $151M Hip Verdict Over Expert Pay
- Halt Medical Gets OK On Reduced Breakup Fee Proposal
- Indian Lender Can't Execute Delhi Arbitral Win Elsewhere
- Wash., NM AGs Investigating Eli Lilly's Insulin Pricing
- Bayer, Janssen Score Win In 1st Xarelto Trial
- Pa. Judge Urged To Rethink Midtrial Toss Of Risperdal Suit
- Fed. Circ. Affirms Rejection Of Cancer Therapy Patent Claims
- Akorn Hit With Derivative Suit Over $4.3B Fresenius Deal
- DOJ Raids Perrigo In Generic Drug Price-Fixing Probe
- Express Scripts Seeks Quick Win In Pharmacy Antitrust Suit
- Pfizer Must Face NYU Cancer Drug Royalties Row, Court Says
- Ex-MLB Player's Stock Deal Too Good To Be True, Jury Told
- Test Strips Seller Faces Eavesdrop Sanctions In Abbott Row
- Goldberg Segalla Adds Patent Pro As IP Chair
- FDA Warning Wire: Agency Finds Falsified Import Docs
- 10th Circ. Nixes Pot Dispensary's Challenge To IRS Probe
- Hogan Lovells Hires Pharma Partner From DEA
- Pre- And Post-AIA On-Sale Bar After Medicines And Helsinn
- Kimberly-Clark Sues Halyard Over $350M Verdict Duty Claim
- WEN Hair Care Line Bangs Out $26.3M Deal In Hair Loss Suit
- Theranos Settles $96M Investor Damage, Share Swap Suits
- Roche Ducks $25M Accutane Verdict In NJ, Gets New Trial
- What Lawyers Should Know To Avoid Online Scams
- GSK, Hospira Trade Blame For Failed Flu Vaccine Deal
- 1 Firm Grabs Spotlight Amid IPO Resurgence In April
- Escobar Ruling Helps Genentech Beat Avastin FCA Suit
- Pharmavite Reaches $1.9M Settlement Over False Ad Claims
- Valeant Securities Fraud Case Lives, Could Lose Debt Claims
- FDA Wants More Info On New Schizophrenia Drug Trials
- Shire Asks Fed. Circ. To Undo Generic's Win In Lialda Suit
- Fed. Circ. Defines Scope Of AIA On-Sale Bar Rule
- Sex Drugs Labeled As Natural Contain Viagra, Suit Says
- Negligent Undertaking Liability Only Goes So Far
- Web Servers: An Overlooked Cybersecurity Risk At Law Firms